FOI release

FOI vaccines

Some or all of the information requested may not have been provided because we required clarification from the requester.

Case reference FOI2024/00641

Received 19 October 2024

Published 20 November 2024

Request

I am also writing to request information under the Freedom of Information Act regarding the safety monitoring of the Repevax vaccine in the UK, with the yellow card reporting scheme. Specifically, I would like to know how many cases of chorioamnionitis have been reported through the Yellow Card Scheme associated with the use of Repevax since its introduction in the UK and how many cases of facial paralysis has been reported through the Yellow card scheme also since its introduction. Please provide any relevant data, reports, or summaries that detail the number of reported cases, as well as any information regarding the investigation or assessment of these reports by the MHRA. I am looking for reports on the whooping cough vaccines such as Repevax, Boostrix and Adacel. Would you kindly tell me where I can find all reports on this subject please?

Response

see attached

Documents

• clinical-overview.pdf (839.8 KB)
• common-responses-Reference list.pdf (259.0 KB)
• FOI-2024-00641 redacted for publication.pdf (130.7 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.